ALZCHEM GROUP AG (ACT.DE) Fundamental Analysis & Valuation

FRA:ACT • DE000A2YNT30

Current stock price

160.8 EUR
-4.8 (-2.9%)
Last:

This ACT.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

9

1. ACT.DE Profitability Analysis

1.1 Basic Checks

  • ACT had positive earnings in the past year.
  • In the past year ACT had a positive cash flow from operations.
  • Each year in the past 5 years ACT has been profitable.
  • ACT had a positive operating cash flow in 4 of the past 5 years.
ACT.DE Yearly Net Income VS EBIT VS OCF VS FCFACT.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M

1.2 Ratios

  • ACT has a Return On Assets of 10.27%. This is amongst the best in the industry. ACT outperforms 94.29% of its industry peers.
  • With an excellent Return On Equity value of 24.76%, ACT belongs to the best of the industry, outperforming 97.14% of the companies in the same industry.
  • Looking at the Return On Invested Capital, with a value of 13.72%, ACT belongs to the top of the industry, outperforming 95.71% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for ACT is significantly above the industry average of 6.99%.
  • The 3 year average ROIC (13.60%) for ACT is below the current ROIC(13.72%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 10.27%
ROE 24.76%
ROIC 13.72%
ROA(3y)9.87%
ROA(5y)8.8%
ROE(3y)24.16%
ROE(5y)24.97%
ROIC(3y)13.6%
ROIC(5y)11.74%
ACT.DE Yearly ROA, ROE, ROICACT.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

1.3 Margins

  • The Profit Margin of ACT (11.29%) is better than 84.29% of its industry peers.
  • In the last couple of years the Profit Margin of ACT has grown nicely.
  • ACT has a Operating Margin of 16.87%. This is amongst the best in the industry. ACT outperforms 87.14% of its industry peers.
  • In the last couple of years the Operating Margin of ACT has grown nicely.
  • Looking at the Gross Margin, with a value of 67.97%, ACT belongs to the top of the industry, outperforming 97.14% of the companies in the same industry.
  • ACT's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 16.87%
PM (TTM) 11.29%
GM 67.97%
OM growth 3Y35.88%
OM growth 5Y14.09%
PM growth 3Y26.76%
PM growth 5Y16.8%
GM growth 3Y11.38%
GM growth 5Y1.65%
ACT.DE Yearly Profit, Operating, Gross MarginsACT.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

9

2. ACT.DE Health Analysis

2.1 Basic Checks

  • ACT has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
  • ACT has less shares outstanding than it did 1 year ago.
  • The number of shares outstanding for ACT has been reduced compared to 5 years ago.
  • ACT has a better debt/assets ratio than last year.
ACT.DE Yearly Shares OutstandingACT.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
ACT.DE Yearly Total Debt VS Total AssetsACT.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • ACT has an Altman-Z score of 4.89. This indicates that ACT is financially healthy and has little risk of bankruptcy at the moment.
  • ACT has a better Altman-Z score (4.89) than 94.29% of its industry peers.
  • The Debt to FCF ratio of ACT is 1.13, which is an excellent value as it means it would take ACT, only 1.13 years of fcf income to pay off all of its debts.
  • ACT's Debt to FCF ratio of 1.13 is amongst the best of the industry. ACT outperforms 92.86% of its industry peers.
  • A Debt/Equity ratio of 0.14 indicates that ACT is not too dependend on debt financing.
  • ACT has a better Debt to Equity ratio (0.14) than 72.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.13
Altman-Z 4.89
ROIC/WACC1.88
WACC7.31%
ACT.DE Yearly LT Debt VS Equity VS FCFACT.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 50M 100M 150M 200M 250M

2.3 Liquidity

  • ACT has a Current Ratio of 2.49. This indicates that ACT is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Current ratio, with a value of 2.49, ACT is in the better half of the industry, outperforming 78.57% of the companies in the same industry.
  • A Quick Ratio of 1.52 indicates that ACT should not have too much problems paying its short term obligations.
  • ACT's Quick ratio of 1.52 is fine compared to the rest of the industry. ACT outperforms 70.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.49
Quick Ratio 1.52
ACT.DE Yearly Current Assets VS Current LiabilitesACT.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. ACT.DE Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an nice 18.57% over the past year.
  • The Earnings Per Share has been growing by 26.48% on average over the past years. This is a very strong growth
  • The Revenue has been growing slightly by 1.42% in the past year.
  • Measured over the past years, ACT shows a quite strong growth in Revenue. The Revenue has been growing by 8.19% on average per year.
EPS 1Y (TTM)18.57%
EPS 3Y28.42%
EPS 5Y26.48%
EPS Q2Q%13.74%
Revenue 1Y (TTM)1.42%
Revenue growth 3Y1.21%
Revenue growth 5Y8.19%
Sales Q2Q%-1.26%

3.2 Future

  • ACT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 26.32% yearly.
  • Based on estimates for the next years, ACT will show a quite strong growth in Revenue. The Revenue will grow by 11.01% on average per year.
EPS Next Y5.53%
EPS Next 2Y15.99%
EPS Next 3Y26.32%
EPS Next 5YN/A
Revenue Next Year7.47%
Revenue Next 2Y12.07%
Revenue Next 3Y12.68%
Revenue Next 5Y11.01%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ACT.DE Yearly Revenue VS EstimatesACT.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M 1B
ACT.DE Yearly EPS VS EstimatesACT.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2 4 6 8 10

More info and screens

Find the best growth stocksShow best growing peers

3

4. ACT.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 25.52, which means the current valuation is very expensive for ACT.
  • Compared to the rest of the industry, the Price/Earnings ratio of ACT is on the same level as its industry peers.
  • When comparing the Price/Earnings ratio of ACT to the average of the S&P500 Index (25.23), we can say ACT is valued inline with the index average.
  • With a Price/Forward Earnings ratio of 24.79, ACT is valued on the expensive side.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ACT indicates a slightly more expensive valuation: ACT is more expensive than 67.14% of the companies listed in the same industry.
  • ACT's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 23.28.
Industry RankSector Rank
PE 25.52
Fwd PE 24.79
ACT.DE Price Earnings VS Forward Price EarningsACT.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, ACT is valued a bit more expensive than 61.43% of the companies in the same industry.
  • ACT's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 41.73
EV/EBITDA 13.65
ACT.DE Per share dataACT.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • The excellent profitability rating of ACT may justify a higher PE ratio.
  • ACT's earnings are expected to grow with 26.32% in the coming years. This may justify a more expensive valuation.
PEG (NY)4.61
PEG (5Y)0.96
EPS Next 2Y15.99%
EPS Next 3Y26.32%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

4

5. ACT.DE Dividend Analysis

5.1 Amount

  • ACT has a Yearly Dividend Yield of 1.29%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 2.38, ACT is paying slightly less dividend.
  • ACT's Dividend Yield is slightly below the S&P500 average, which is at 1.91.
Industry RankSector Rank
Dividend Yield 1.29%

5.2 History

  • The dividend of ACT is nicely growing with an annual growth rate of 19.13%!
Dividend Growth(5Y)19.13%
Div Incr Years5
Div Non Decr Years5
ACT.DE Yearly Dividends per shareACT.DE Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2

5.3 Sustainability

  • 28.66% of the earnings are spent on dividend by ACT. This is a low number and sustainable payout ratio.
  • The dividend of ACT is growing, but earnings are growing more, so the dividend growth is sustainable.
DP28.66%
EPS Next 2Y15.99%
EPS Next 3Y26.32%
ACT.DE Yearly Income VS Free CF VS DividendACT.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M 60M
ACT.DE Dividend Payout.ACT.DE Dividend Payout, showing the Payout Ratio.ACT.DE Dividend Payout.PayoutRetained Earnings

More info and screens

Find the best dividend stocksShow peers with best dividend

ACT.DE Fundamentals: All Metrics, Ratios and Statistics

ALZCHEM GROUP AG

FRA:ACT (3/20/2026, 7:00:00 PM)

160.8

-4.8 (-2.9%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-27
Earnings (Next)04-30
Inst Owners41.61%
Inst Owner ChangeN/A
Ins Owners28%
Ins Owner ChangeN/A
Market Cap1.64B
Revenue(TTM)562.12M
Net Income(TTM)63.46M
Analysts87.27
Price Target180.48 (12.24%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.29%
Yearly Dividend1.79
Dividend Growth(5Y)19.13%
DP28.66%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)13.82%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.27%
EPS NY rev (3m)-7.02%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.43%
Revenue NY rev (3m)-1.96%
Valuation
Industry RankSector Rank
PE 25.52
Fwd PE 24.79
P/S 2.91
P/FCF 41.73
P/OCF 11.95
P/B 6.39
P/tB 6.48
EV/EBITDA 13.65
EPS(TTM)6.3
EY3.92%
EPS(NY)6.49
Fwd EY4.03%
FCF(TTM)3.85
FCFY2.4%
OCF(TTM)13.46
OCFY8.37%
SpS55.22
BVpS25.18
TBVpS24.83
PEG (NY)4.61
PEG (5Y)0.96
Graham Number59.74
Profitability
Industry RankSector Rank
ROA 10.27%
ROE 24.76%
ROCE 19.01%
ROIC 13.72%
ROICexc 16.03%
ROICexgc 16.16%
OM 16.87%
PM (TTM) 11.29%
GM 67.97%
FCFM 6.98%
ROA(3y)9.87%
ROA(5y)8.8%
ROE(3y)24.16%
ROE(5y)24.97%
ROIC(3y)13.6%
ROIC(5y)11.74%
ROICexc(3y)15.49%
ROICexc(5y)13.01%
ROICexgc(3y)15.65%
ROICexgc(5y)13.15%
ROCE(3y)18.84%
ROCE(5y)16.26%
ROICexgc growth 3Y18.84%
ROICexgc growth 5Y13.25%
ROICexc growth 3Y18.94%
ROICexc growth 5Y13.21%
OM growth 3Y35.88%
OM growth 5Y14.09%
PM growth 3Y26.76%
PM growth 5Y16.8%
GM growth 3Y11.38%
GM growth 5Y1.65%
F-Score7
Asset Turnover0.91
Health
Industry RankSector Rank
Debt/Equity 0.14
Debt/FCF 1.13
Debt/EBITDA 0.3
Cap/Depr 366.97%
Cap/Sales 17.4%
Interest Coverage 54.63
Cash Conversion 112.78%
Profit Quality 61.81%
Current Ratio 2.49
Quick Ratio 1.52
Altman-Z 4.89
F-Score7
WACC7.31%
ROIC/WACC1.88
Cap/Depr(3y)203.37%
Cap/Depr(5y)168.11%
Cap/Sales(3y)9.66%
Cap/Sales(5y)8.22%
Profit Quality(3y)109.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)18.57%
EPS 3Y28.42%
EPS 5Y26.48%
EPS Q2Q%13.74%
EPS Next Y5.53%
EPS Next 2Y15.99%
EPS Next 3Y26.32%
EPS Next 5YN/A
Revenue 1Y (TTM)1.42%
Revenue growth 3Y1.21%
Revenue growth 5Y8.19%
Sales Q2Q%-1.26%
Revenue Next Year7.47%
Revenue Next 2Y12.07%
Revenue Next 3Y12.68%
Revenue Next 5Y11.01%
EBIT growth 1Y20.86%
EBIT growth 3Y37.52%
EBIT growth 5Y23.43%
EBIT Next Year45.22%
EBIT Next 3Y32.94%
EBIT Next 5Y22.28%
FCF growth 1Y-36.78%
FCF growth 3YN/A
FCF growth 5Y14.56%
OCF growth 1Y30.31%
OCF growth 3YN/A
OCF growth 5Y22.98%

ALZCHEM GROUP AG / ACT.DE Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ALZCHEM GROUP AG?

ChartMill assigns a fundamental rating of 7 / 10 to ACT.DE.


What is the valuation status for ACT stock?

ChartMill assigns a valuation rating of 3 / 10 to ALZCHEM GROUP AG (ACT.DE). This can be considered as Overvalued.


Can you provide the profitability details for ALZCHEM GROUP AG?

ALZCHEM GROUP AG (ACT.DE) has a profitability rating of 9 / 10.


Can you provide the financial health for ACT stock?

The financial health rating of ALZCHEM GROUP AG (ACT.DE) is 9 / 10.


What is the earnings growth outlook for ALZCHEM GROUP AG?

The Earnings per Share (EPS) of ALZCHEM GROUP AG (ACT.DE) is expected to grow by 5.53% in the next year.